In chronic HF, empagliflozin reduced a composite of CV death or HF hospitalization across kidney risk categories.
Where this comes from
- Record sourced from PubMed, PMID 37665991.
- Also identified by DOI 10.7326/J23-0065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Butler J, Packer M, Siddiqi TJ, et al. <b>Efficacy of empagliflozin in patients with heart failure across kidney risk categories.</b> J Am Coll Cardiol. 2023;81:1902-1914. 37164523.
Medical subject headings
- Benzhydryl Compounds
- Glucosides